Twin Capital Management upped its stake in Bristol-Myers Squibb by 11.2% in Q4, grabbing 92,094 shares valued over $5.2 ...

Bristol-Myers Squibb Co. got dismissal of a lawsuit alleging the company used reverse-payment agreements to delay the generic ...

The pharmaceutical and healthcare sectors were previously viewed as a relative safe haven from the tariff-induced market turmoil. The Health Care Select Sector SPDR exchange-traded fund XLV fell 7.8% ...

A New York City federal court has dismissed a proposed class action lawsuit against Bristol Myers Squibb that accused the ...

Bristol-Myers Squibb Down Nearly 6%, on Pace for Largest Percent Decrease Since April 2024 — Data Talk Bristol-Myers Squibb Company (BMY) is currently at $49.98, down $3.09 or 5.82% ...

Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing sham patent ...

Shares in major U.S. and European pharmaceutical companies fell sharply Wednesday, underperforming a broader market downturn, after U.S. President Donald Trump said the country would soon impose “a ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Sell rating on Bristol-Myers Squibb (BMY – Research Report), with a ...

A federal judge in New York has dismissed a proposed class action filed by health insurer Blue Cross Blue Shield of Louisiana ...

Find out how Bristol Myers Squibb was honored for 50 years of service in Lawrence, from local support to global medical ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...